A 32-year-old multigravida at 32 weeks of gestation with known gestational diabetes mellitus (diagnosed at 24 weeks) presents for routine follow-up. She has been on medical nutrition therapy for 6 weeks. Her home blood glucose log shows: fasting 98–102 mg/dL, 2-hour postprandial 155–165 mg/dL. She is compliant with diet and exercise. What is the most appropriate next step in management?

Explanation

## Assessment of Glycemic Control Failure **Key Point:** After 2 weeks of optimized medical nutrition therapy (MNT), if fasting glucose remains ≥95 mg/dL or 2-hour postprandial ≥120 mg/dL, pharmacotherapy must be initiated. This patient has failed MNT and requires insulin. ## Target vs. Actual Glucose Levels | Parameter | Target (mg/dL) | Patient's Value (mg/dL) | Status | |-----------|----------------|------------------------|--------| | Fasting | <95 | 98–102 | **Above target** | | 2-hour postprandial | <120 | 155–165 | **Significantly above target** | **High-Yield:** Persistent hyperglycemia despite adequate MNT (6 weeks) indicates need for pharmacotherapy. **Insulin is preferred over metformin in pregnancy** because: - Insulin does not cross the placenta - Metformin crosses placenta and long-term fetal safety data are limited - Insulin is the gold standard for GDM pharmacotherapy ## Insulin Initiation in GDM ```mermaid flowchart TD A[MNT Failed: Persistent Hyperglycemia]:::outcome --> B[Initiate Insulin]:::action B --> C[Start NPH/Basal Insulin]:::action C --> D[Typical starting dose: 10 units bedtime]:::action D --> E[Review in 3 days]:::action E --> F{Fasting glucose at target?}:::decision F -->|Yes| G[Continue + add rapid-acting if needed]:::action F -->|No| H[Increase NPH by 2-4 units]:::action H --> E ``` **Clinical Pearl:** NPH (neutral protamine Hagedorn) is preferred for basal insulin in pregnancy because of its long track record of safety. Rapid-acting insulins (lispro, aspart) are added for postprandial control if needed. **Mnemonic: INSULIN in GDM** — **I**nsulin is **N**ot crossing placenta, **S**afe in pregnancy, **U**nlike metformin, **L**ong-acting (NPH) preferred, **I**nitiated when **N**utrition fails ## Monitoring After Insulin Initiation - Review glucose logs in **3 days** (not 2 weeks) to assess response and titrate dose - Target: fasting <95 mg/dL, 2-hour postprandial <120 mg/dL - Adjust NPH by 2–4 units every 3 days until target achieved [cite:ICMR-INDIAB GDM Guidelines 2018; ACOG Practice Bulletin 190]